Triple

T22690169
Position Surface form Disambiguated ID Type / Status
Subject CYP1A2 E561029 entity
Predicate substrateOf P37222 FINISHED
Object amitriptyline NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: amitriptyline | Statement: [CYP1A2, substrateOf, amitriptyline]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: amitriptyline
Context triple: [CYP1A2, substrateOf, amitriptyline]
  • A. imipramine
    Imipramine is a tricyclic antidepressant primarily used to treat major depressive disorder and sometimes anxiety and certain types of chronic pain.
  • B. Cymbalta
    Cymbalta is a prescription antidepressant medication (duloxetine) commonly used to treat major depressive disorder, generalized anxiety disorder, and certain types of chronic pain.
  • C. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • D. carbamazepine
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • E. clozapine
    Clozapine is an atypical antipsychotic medication primarily used to treat treatment-resistant schizophrenia and reduce the risk of recurrent suicidal behavior in such patients.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: amitriptyline
Target entity description: Amitriptyline is a tricyclic antidepressant primarily used to treat major depressive disorder, neuropathic pain, and migraine prophylaxis.
  • A. imipramine
    Imipramine is a tricyclic antidepressant primarily used to treat major depressive disorder and sometimes anxiety and certain types of chronic pain.
  • B. Cymbalta
    Cymbalta is a prescription antidepressant medication (duloxetine) commonly used to treat major depressive disorder, generalized anxiety disorder, and certain types of chronic pain.
  • C. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • D. carbamazepine
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • E. clozapine
    Clozapine is an atypical antipsychotic medication primarily used to treat treatment-resistant schizophrenia and reduce the risk of recurrent suicidal behavior in such patients.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789a1fd08190bce5fa0babe695d3 completed April 29, 2026, 3:18 a.m.
Created at: April 17, 2026, 3:13 p.m.